Ovarian Cancer Drug Given Fast-Track Approval

Rubraca’s use is specific to women with a mutation of the BRCA gene, FDA said (HealthDay News) — The anti-cancer drug Rubraca (rucaparib) has been granted accelerated approval by the U.S. Food and Drug Administration to treat advanced ovarian cancer. The approval is limited to cases where the cancer is caused by specific gene mutations…

Details

Relieve Vaginal Pain Without Surgery or Hormone Replacement Therapy

ThermiVa is a non-surgical procedure that works to eliminate vaginal pain. No surgery, no downtime, no medication, no additional pain. ThermiVa is a simple solution to troublesome vaginal pain. Women often experience vaginal pain such as vaginal dryness and discomfort during intercourse or urination. These problems tend to rise when estrogen production significantly decreases. Estrogen…

Details